PCOS is often treated as a reproductive issue, but at its core, it's a metabolic and hormonal condition that affects far more than the ovaries.

Insulin resistance is present in 70-80% of people with PCOS, regardless of weight. When cells don't respond properly to insulin, the body produces more of it. Elevated insulin stimulates the ovaries to produce excess androgens and disrupts normal ovulation.

This creates a cascade of effects:

• Type 2 diabetes risk: People with PCOS are 4-7 times more likely to develop type 2 diabetes • Cardiovascular risk: Higher rates of high blood pressure, elevated cholesterol, and cardiovascular disease • Non-alcoholic fatty liver disease (NAFLD): Significantly more common in PCOS • Chronic low-grade inflammation: Elevated inflammatory markers are common and worsen insulin resistance

This is why treatments that address insulin resistance — whether through medication like metformin, supplements like inositol, or lifestyle changes — often improve multiple PCOS symptoms simultaneously.

Understanding PCOS as metabolic reframes the conversation. Weight gain isn't a personal failure — it's a biochemical consequence of insulin resistance. Symptoms aren't random — they're connected through hormonal and metabolic pathways.